Banco Santander S.A. Reduces Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Banco Santander S.A. lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 52,768 shares of the medical equipment provider’s stock after selling 1,987 shares during the quarter. Banco Santander S.A.’s holdings in Intuitive Surgical were worth $27,543,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter valued at $26,000. BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical during the fourth quarter valued at $28,000. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter valued at $31,000. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the third quarter valued at $33,000. Finally, Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical during the fourth quarter valued at $36,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. Truist Financial increased their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Finally, Barclays raised their price target on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $518.26 on Friday. The stock’s 50-day moving average is $571.36 and its 200-day moving average is $531.20. The company has a market cap of $184.59 billion, a price-to-earnings ratio of 80.85, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 489 shares of the firm’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $533.18, for a total transaction of $260,725.02. Following the sale, the senior vice president now directly owns 2,091 shares in the company, valued at approximately $1,114,879.38. This trade represents a 18.95 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Fredrik Widman sold 810 shares of the firm’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the sale, the vice president now owns 473 shares in the company, valued at approximately $271,397.94. The trade was a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,579 shares of company stock worth $7,756,844 in the last three months. 0.90% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.